SLE‐associated myelitis successfully treated by rituximab
Abstract Systemic lupus erythematosus (SLE) is an autoimmune disease. Transverse myelitis (TM) is one of the rare neurological manifestations of SLE. Here, we present a case of SLE in which TM precede other symptoms and successfully treated by Rituximab.
Main Authors: | Alireza Khabbazi, Leyla Ghadakchi, Yalda Yazdani, Elham Habibzade, Saba Mehrtabar, Amirreza Khalaji |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-11-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.6622 |
Similar Items
-
Familial Mediterranean Fever and Transverse Myelitis: A Causal Relation?
by: Ali Motahharynia, et al.
Published: (2023-03-01) -
Persistent “MRI-negative” lupus myelitis-disease presentation, immunological profile and outcome
by: Shambaditya Das, et al.
Published: (2022-10-01) -
New onset urinary incontinence in a pediatric patient with transverse myelitis
by: Eitan Glucksman, et al.
Published: (2023-01-01) -
Pediatric Acute Longitudinal Extensive Transverse Myelitis Secondary to Neuroborreliosis
by: Sana Khan, et al.
Published: (2015-07-01) -
Subacute transverse myelitis with Lyme profile dissociation
by: Ajjan, Mohammed, et al.
Published: (2008-06-01)